Literature DB >> 19299632

Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR.

Jean-Marc Olivot1, Michael Mlynash, Vincent N Thijs, Archana Purushotham, Stephanie Kemp, Maarten G Lansberg, Lawrence Wechsler, Roland Bammer, Michael P Marks, Gregory W Albers.   

Abstract

BACKGROUND AND
PURPOSE: Acute ischemic lesions with restricted diffusion can resolve after early recanalization. The impact of superimposed perfusion abnormalities on the fate of acute diffusion lesions is unclear.
METHODS: Data were obtained from DEFUSE, a prospective multicenter study of patients treated with IV tPA 3 to 6 hours after stroke onset. Thirty-two patients with baseline diffusion and perfusion lesions and 30 day FLAIR scans were coregistered. The acute diffusion lesion was divided into 3 regions according to the Tmax delay of the superimposed perfusion lesion: normal baseline perfusion; mild-moderately hypoperfused (2 s<Tmax<or=8 s) and severely hypoperfused (Tmax >8 s). The reversal rate was calculated as the percentage of the acute diffusion lesion that did not overlap with the final infarct on 30-day FLAIR. Diffusion reversal rates were compared based on whether a favorable clinical response occurred and whether early recanalization was achieved.
RESULTS: On average, 54% of the acute diffusion lesion volume had normal perfusion. Diffusion reversal rates were significantly increased among cases with favorable clinical response and in patients with early recanalization, especially in regions with normal baseline perfusion. The portion of the diffusion lesion with normal perfusion had significantly higher mean apparent diffusion coefficient values and reversal rates.
CONCLUSIONS: Acute ischemic lesions with restricted diffusion are most likely to recover if reperfusion occurs within 6 hours of symptom onset, and reversibility is associated with early recanalization and favorable clinical outcome. We propose the term RADAR (Reversible Acute Diffusion lesion Already Reperfused) to describe regions of acute restricted diffusion with normal perfusion.

Entities:  

Mesh:

Year:  2009        PMID: 19299632      PMCID: PMC2709804          DOI: 10.1161/STROKEAHA.108.538082

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Recovery of apparent diffusion coefficient after ischemia-induced spreading depression relates to cerebral perfusion gradient.

Authors:  J Röther; A J de Crespigny; H D'Arceuil; K Iwai; M E Moseley
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

2.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

3.  Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats.

Authors:  M E Moseley; J Kucharczyk; J Mintorovitch; Y Cohen; J Kurhanewicz; N Derugin; H Asgari; D Norman
Journal:  AJNR Am J Neuroradiol       Date:  1990-05       Impact factor: 3.825

4.  Severe ADC decreases do not predict irreversible tissue damage in humans.

Authors:  Jens Fiehler; Mascha Foth; Thomas Kucinski; Renée Knab; Michael von Bezold; Cornelius Weiller; Hermann Zeumer; Joachim Röther
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

5.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.

Authors:  C S Kidwell; J L Saver; J Mattiello; S Starkman; F Vinuela; G Duckwiler; Y P Gobin; R Jahan; P Vespa; M Kalafut; J R Alger
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

6.  Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.

Authors:  Ludy C Shih; Jeffrey L Saver; Jeffry R Alger; Sidney Starkman; Megan C Leary; Fernando Vinuela; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; J Pablo Villablanca; Paul M Vespa; Chelsea S Kidwell
Journal:  Stroke       Date:  2003-05-08       Impact factor: 7.914

7.  Predictors of apparent diffusion coefficient normalization in stroke patients.

Authors:  Jens Fiehler; Karina Knudsen; Thomas Kucinski; Chelsea S Kidwell; Jeffry R Alger; Götz Thomalla; Bernd Eckert; Oliver Wittkugel; Cornelius Weiller; Hermann Zeumer; Joachim Röther
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

8.  Late secondary ischemic injury in patients receiving intraarterial thrombolysis.

Authors:  Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

Review 9.  Viability thresholds and the penumbra of focal ischemia.

Authors:  K A Hossmann
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

10.  Optimal Tmax threshold for predicting penumbral tissue in acute stroke.

Authors:  Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Roland Bammer; Michael P Marks; Gregory W Albers
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

View more
  28 in total

1.  Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct Core.

Authors:  Christopher D d'Esterre; Richard I Aviv; Laura Morrison; Enrico Fainardi; Ting Yim Lee
Journal:  Transl Stroke Res       Date:  2015-04-15       Impact factor: 6.829

2.  Rapid Apparent Diffusion Coefficient Evolution After Early Revascularization.

Authors:  Amie W Hsia; Marie Luby; Kaylie Cullison; Shannon Burton; Rocco Armonda; Ai-Hsi Liu; Richard Leigh; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour
Journal:  Stroke       Date:  2019-06-26       Impact factor: 7.914

3.  Predictors of reperfusion in patients with acute ischemic stroke.

Authors:  A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

4.  The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent.

Authors:  Bruce C V Campbell; Archana Purushotham; Soren Christensen; Patricia M Desmond; Yoshinari Nagakane; Mark W Parsons; Maarten G Lansberg; Michael Mlynash; Matus Straka; Deidre A De Silva; Jean-Marc Olivot; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-20       Impact factor: 6.200

5.  The Need for Better Data on Patients with Acute Stroke Who Are Not Treated Because of Unfavorable Imaging.

Authors:  M Goyal; B K Menon; M A Almekhlafi; A Demchuk; M D Hill
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-19       Impact factor: 3.825

6.  Reply.

Authors:  J C Benson; S Payabvash; B Hoffman; M Oswood; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-13       Impact factor: 3.825

Review 7.  Physiologic imaging in acute stroke: Patient selection.

Authors:  Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco
Journal:  Interv Neuroradiol       Date:  2015-06-10       Impact factor: 1.610

Review 8.  Heterogeneity in the penumbra.

Authors:  Gregory J del Zoppo; Frank R Sharp; Wolf-Dieter Heiss; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

9.  Early diffusion-weighted imaging reversal after endovascular reperfusion is typically transient in patients imaged 3 to 6 hours after onset.

Authors:  Manabu Inoue; Michael Mlynash; Soren Christensen; Hayley M Wheeler; Matus Straka; Aaryani Tipirneni; Stephanie M Kemp; Greg Zaharchuk; Jean-Marc Olivot; Roland Bammer; Maarten G Lansberg; Gregory W Albers
Journal:  Stroke       Date:  2014-02-20       Impact factor: 7.914

Review 10.  Plasminogen activators and ischemic stroke: conditions for acute delivery.

Authors:  Gregory J del Zoppo
Journal:  Semin Thromb Hemost       Date:  2013-03-28       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.